Familial Alzheimer's disease: genetic analysis related to disease heterogeneity, Down syndrome and human brain evolution.
Etiologically heterogeneous subgroups of patients with Alzheimer's disease (AD) exist and need to be distinguished so as to better identify genetic causes of familial cases. Furthermore, the presence of AD neuropathology in Down syndrome (trisomy 21) subjects older than 35 years suggests that AD in some cases is caused by dysregulation of expression of genes on chromosome 21. Cerebral metabolic abnormalities in life, and the distribution of AD neuropathology in the post-mortem brain, indicate that AD involves the association neocortices and subcortical regions with which they evolved during evolution of the human brain. Accordingly, understanding the molecular basis of this evolution should elucidate the genetic basis of AD, whereas knowing the genetics of AD should be informative about the genomic changes which promoted brain evolution.
Schapiro
M B
MB
Laboratory of Neurosciences, National Institute on Aging, Bethesda, MD 20892.
Rapoport
S I
SI
D000328:Adult; D000544:Alzheimer Disease / Q000235:genetics* / Q000473:pathology; D002891:Chromosomes, Human, Pair 21; D004314:Down Syndrome / Q000473:pathology*; D006801:Humans